MLTX logo

MoonLake Immunotherapeutics (MLTX) EV/EBITDA

EV/EBITDA:

-1.50-0.03(-2.04%)
November 3, 2025

Summary

  • As of today, MLTX EV/EBITDA is -1.50, with a fall of -0.03 (-2.04%) during the most recent trading session on November 3, 2025.
  • Over the past year, MLTX EV/EBITDA has increased by +21.17 (+93.38%).
  • MLTX EV/EBITDA is now -525.00% below its all-time high of -0.24.

Performance

MLTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherMLTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

MLTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day-2.0%+2.2%+1.0%
1M1 Month-59.6%+60.4%+21.0%
3M3 Months+90.1%-90.1%-80.7%
6M6 Months+88.9%-86.9%-75.9%
YTDYTD+92.8%-90.0%-81.2%
1Y1 Year+93.4%-87.9%-78.2%
5Y5 Years-+142.4%-1.1%

MLTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month-0.94-59.6%-1.65+9.1%
3M3-Month-0.24-525.0%-18.08+91.7%
6M6-Month-0.24-525.0%-18.08+91.7%
1Y1-Year-0.24-525.0%-28.21+94.7%
3Y3-Year-0.24-525.0%-61.99+97.6%
5Y5-Year-0.24-525.0%-1492+99.9%
All-TimeAll-Time-0.24-525.0%-1492+99.9%

MLTX EV/EBITDA History

DateValue
2025
-1.50(+92.8%)
2024
-20.96(+63.9%)
2023
-58.11(-1019.7%)
DateValue
2022
-5.19(-121.8%)
2021
-2.34(+99.8%)
2020
-1333.00

FAQ

  • What is MoonLake Immunotherapeutics EV/EBITDA?
  • What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
  • What is MLTX EV/EBITDA year-to-date change?
  • What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

What is MoonLake Immunotherapeutics EV/EBITDA?

The current EV/EBITDA of MLTX is -1.50

What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24

What is MLTX EV/EBITDA year-to-date change?

MoonLake Immunotherapeutics EV/EBITDA has changed by +19.46 (+92.84%) since the beginning of the year

What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

Over the past year, MLTX EV/EBITDA has changed by +21.17 (+93.38%)
On this page